Perspectives & insights
Dive deep into our latest commentary on policy issues.
Featured
What happens to medical innovation when policies undervalue medicines?
This is the third blog of a three-part series highlighting the Value of Health in the United States.
Why do new medicines reach patients faster in the United States?
This is the second blog of a three-part series highlighting the Value of Health in the United States.
How have new medicines improved health and life expectancy in the United States?
This is the first blog of a three-part series highlighting the Value of Health in the United States.
